Nils Erik Gilhus

Research interests

Publications

• Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

  The Lancet Neurology · 2023 · 10.1016/s1474-4422(23)00080-7

• Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

  JAMA Neurology · 2022 · https://doi.org/10.1001/jamaneurol.2022.1269

• International Consensus Guidance for Management of Myasthenia Gravis

  Neurology · 2020 · https://doi.org/10.1212/wnl.0000000000011124

• Myasthenia gravis

  Nature Reviews Disease Primers · 2019 · https://doi.org/10.1038/s41572-019-0079-y

• Myasthenia Gravis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmra1602678

• International consensus guidance for management of myasthenia gravis

  Neurology · 2016 · https://doi.org/10.1212/wnl.0000000000002790

• Myasthenia gravis — autoantibody characteristics and their implications for therapy

  Nature Reviews Neurology · 2016 · 10.1038/nrneurol.2016.44

• Myasthenia gravis: subgroup classification and therapeutic strategies

  The Lancet Neurology · 2015 · https://doi.org/10.1016/s1474-4422(15)00145-3

• Guidelines for treatment of autoimmune neuromuscular transmission disorders

  European Journal of Neurology · 2010 · 10.1111/j.1468-1331.2010.03019.x

• EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

  European Journal of Neurology · 2008 · https://doi.org/10.1111/j.1468-1331.2008.02246.x

• Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

  European Journal of Neurology · 2006 · https://doi.org/10.1111/j.1468-1331.2006.01493.x

Current projects

No projects listed.